Assistant Professor, Radiation Oncology, Oakland University Wm Beaumont SOM
Radiation Oncology
Dr. Jannifer S. Stromberg, MD
|
|
Give Review
Doctor Jannifer S. Stromberg, MD is an expert in the field of Radiation Oncology. She went to medical school at University of Michigan Medical School. Jannifer Stromberg is a published physician. She published 29 publications, including: 'The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure.' Jannifer Stromberg accepts Medicare.
Publications
- Implementation of an oncology exercise and wellness rehabilitation program to enhance survivorship: the Beaumont Health System experience.
- Impact of the Number of Cautionary and/or Unsuitable Risk Factors on Outcomes After Accelerated Partial Breast Irradiation.
- Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
- Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endome...
- Pathologic evidence of dose-response and dose-volume relationships for prostate cancer treated with combined external beam radiotherapy and high-dose-rate brachytherapy.
- Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy.
- Regulation of HSP70 and HSP28 gene expression: absence of compensatory interactions.
- Langerhans cell histiocytosis involving the sphenoid sinus and superior orbital fissure.
- Active breathing control (ABC) for Hodgkin's disease: reduction in normal tissue irradiation with deep inspiration and implications for treatment.
- The use of active breathing control (ABC) to reduce margin for breathing motion.
- Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines.
- The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost. Correlation with biochemical failure.
- Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.
- Brachytherapy boost techniques for locally advanced prostate cancer.
- Conformal high dose rate iridium-192 boost brachytherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam t...
- An analysis of clinical and treatment related prognostic factors on outcome using biochemical control as an end-point in patients with prostate cancer treated with ext...
- Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer.
- Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
- Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy.
- Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer.
- A comprehensive review of prostate cancer brachytherapy: defining an optimal technique.
- The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam i...
- Radiotherapy options for localized prostate cancer based upon pretreatment serum prostate-specific antigen levels and biochemical control: a comprehensive review of th...
- Assessing the variability of outcome for patients treated with localized prostate irradiation using different definitions of biochemical control.
- Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate impla...
- Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
- Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer.
- Prostate volume reduction with androgen deprivation therapy before interstitial brachytherapy.
Schools
University of Mi Med Sch
William Beaumont Hospital
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
William Beaumont Hospital -
University of Michigan Medical School
Hospital
-
Beaumont Hospital - Royal Oak
Drug Facts
| NPI NUMBER | 1740240894 | |
| NPPES Provider LastName | STROMBERG | |
| NPPES Provider FirstName | JANNIFER | |
| NPPES Provider ZIPCode | 480851117 | |
| NPPES Provider State | MI | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 101.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 18.81 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1740240894 |
| Last Name Of The Provider | STROMBERG |
| First Name Of The Provider | JANNIFER |
| View All |
Similar Doctors
|
|
Dr. Gary S. Gustafson, MD |
|
|
Dr. Gregory S. Gustafson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sirisha Nandalur, MD
This Doctor is OpenDoctor Recommended.
|